SCHEMBL27224054

SCHEMBL27224054

CCOC(=O)c1[nH]ccc1NCc1ccc(Cl)cc1C1CCCCN1C(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.45
▸ ALOX15 P16050 1/20 0.42
▸ KMT2A Q03164 4/20 0.41
▸ LMNA P02545 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ NPSR1 Q6W5P4 3/20 0.41
▸ TSHR P16473 3/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ F2 P00734 2/20 0.39
▸ POLB P06746 2/20 0.37
▸ TP53 P04637 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MDM2 Q00987 3/20 0.35
▸ AHCY P23526 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ F10 P00742 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30749308 1.00 ALDH1A1 (0.45) ALDH1A1ALOX15KMT2ALMNAMEN1
SCHEMBL30028767 0.98 ALDH1A1 (0.47) ALDH1A1ALOX15KMT2ALMNAMEN1
SCHEMBL27224083 0.98 ALDH1A1 (0.47) ALDH1A1ALOX15KMT2ALMNAMEN1
SCHEMBL27223533 0.90 F2 (0.41) ALDH1A1ALOX15KMT2ALMNAMEN1
SCHEMBL30749239 0.89 KMT2A (0.47) ALDH1A1ALOX15KMT2ALMNAMEN1
SCHEMBL27223426 0.89 KMT2A (0.47) ALDH1A1ALOX15KMT2ALMNAMEN1
SCHEMBL30749295 0.89 ALOX15 (0.39) ALDH1A1ALOX15KMT2ALMNAMEN1
SCHEMBL27224063 0.89 ALOX15 (0.39) ALDH1A1ALOX15KMT2ALMNAMEN1
SCHEMBL30749254 0.88 KMT2A (0.46) ALDH1A1ALOX15KMT2ALMNAMEN1
SCHEMBL27224042 0.88 KMT2A (0.46) ALDH1A1ALOX15KMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-05-23 — — US disclosed
WO-2024038131-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-02-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE MPO, XDH, EPX ALDH1A1 502/4885ALOX15 557/4885KMT2A 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback